(Q84590427)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Phase I study of irinotecan by 24-h intravenous infusion in combination with 5-fluorouracil in metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

metastatic colon cancer

1 reference

1 reference

1 reference

Mariko Kambe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hiroaki Kikuchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Makio Gamo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Takashi Yoshioka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yasuo Ohashi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Ryunosuke Kanamaru

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

26 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

150-154

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-011-0272-9

8 February 2020

exact match

0 references

cites work

Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).

1 reference

12 December 2020

A Phase II study of irinotecan in combination with 120-h infusion of 5-fluorouracil in patients with metastatic colorectal carcinoma: Japan Clinical Oncology Group Study (JCOG9703).

1 reference

12 December 2020

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11

1 reference

12 December 2020

Phase I/II study of twenty-four-hour infusion of irinotecan in combination with oral UFT plus leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

12 December 2020

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

12 December 2020

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

12 December 2020

Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development

1 reference

12 December 2020

Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis

1 reference

12 December 2020

Phase I/II study of 24-hour infusion of irinotecan combined with oral UFT for metastatic colorectal cancer

1 reference

12 December 2020

Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo

1 reference

12 December 2020

Prospective phase II study of FOLFIRI for mCRC in Japan, including the analysis of UGT1A1 28/6 polymorphisms.

1 reference

12 December 2020

10.1007/S10147-011-0272-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21786211%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference